{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T14:39:26Z","timestamp":1714228766155},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008518","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T22:01:19Z","timestamp":1509573679000},"page":"e8518","source":"Crossref","is-referenced-by-count":5,"title":["Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Fu-Biao","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian-Xing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-63-20210226","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"R2-63-20210226","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/annonc\/mdw414","article-title":"Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment","volume":"27","author":"Voican","year":"2016","journal-title":"Ann Oncol"},{"key":"R3-63-20210226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MEG.0000000000000749","article-title":"Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience","volume":"29","author":"Papadopoulos","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R4-63-20210226","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2893.2010.01386.x","article-title":"Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy","volume":"18","author":"Li","year":"2011","journal-title":"J Viral Hepat"},{"key":"R5-63-20210226","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10517-015-2787-y","article-title":"Chronodependent effect of interleukin-2 on mouse spleen cells in the model of cyclophosphamide immunosuppression","volume":"158","author":"Shurlygina","year":"2015","journal-title":"Bull Exp Biol Med"},{"key":"R6-63-20210226","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R7-63-20210226","first-page":"888","article-title":"The guideline of prevention and treatment for chronic hepatitis B: a 2015 update","volume":"23","author":"Hou","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R8-63-20210226","first-page":"1","article-title":"S. Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"R9-63-20210226","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","article-title":"Hepatitis B vaccines: WHO position paper--recommendations.","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"R10-63-20210226","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1007\/s10072-009-0145-4","article-title":"Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks","volume":"30","author":"Rinaldi","year":"2009","journal-title":"Neurol Sci"},{"key":"R11-63-20210226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"R12-63-20210226","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MOH.0b013e32834bac10","article-title":"Challenges in hepatitis B detection among blood donors","volume":"18","author":"Allain","year":"2011","journal-title":"Curr Opin Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:39:37Z","timestamp":1620959977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711030-00063"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":12,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008518","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}